High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group
- PMID: 7504031
- DOI: 10.1093/infdis/168.6.1343
High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group
Abstract
Results of serologic tests were correlated with hepatitis C virus (HCV) viremia, determined by a cDNA polymerase chain reaction assay to detect HCV RNA, in 340 Danish dialysis patients; of these, 28 (8.2%) were positive for antibodies to HCV (anti-HCV) with second-generation ELI-SAs. HCV RNA was found in sera from 27 of these 28 anti-HCV-positive patients. However, 8 dialysis patients had detectable levels of HCV RNA but were anti-HCV-negative with second-generation ELISAs. Among the 35 HCV-infected dialysis patients 16 were positive, 7 indeterminate, and 12 negative with the second-generation RIBA. More than 60% of patients with evidence of ongoing liver disease had HCV infection. Thus, current commercially available antibody tests did not accurately reflect the HCV status in dialysis patients. A relatively high prevalence (> 10%) of HCV RNA, closely associated with liver disease, was found among dialysis patients in a low-prevalence area of the world.
Similar articles
-
Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.J Med Virol. 1991 Dec;35(4):253-8. doi: 10.1002/jmv.1890350409. J Med Virol. 1991. PMID: 1724983
-
Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).Nephrol Dial Transplant. 1995;10(2):234-9. Nephrol Dial Transplant. 1995. PMID: 7538650
-
Hepatitis C virus infection in hemodialysis patients: comparison of two new hepatitis C antibody assays with a second-generation assay.J Am Soc Nephrol. 1995 Nov;6(5):1439-44. doi: 10.1681/ASN.V651439. J Am Soc Nephrol. 1995. PMID: 8589320
-
Testing for HCV markers.Dev Biol Stand. 1993;81:77-84. Dev Biol Stand. 1993. PMID: 7513661 Review.
-
[Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].Nihon Rinsho. 1993 Feb;51(2):329-33. Nihon Rinsho. 1993. PMID: 7681883 Review. Japanese.
Cited by
-
Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients.Gut. 2002 Sep;51(3):429-33. doi: 10.1136/gut.51.3.429. Gut. 2002. PMID: 12171969 Free PMC article.
-
Cell therapies and regenerative medicine.Hepatol Int. 2014 Apr;8(2):158-65. doi: 10.1007/s12072-013-9512-6. Epub 2014 Jan 19. Hepatol Int. 2014. PMID: 26202498
-
Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients.J Clin Microbiol. 2005 Jan;43(1):414-20. doi: 10.1128/JCM.43.1.414-420.2005. J Clin Microbiol. 2005. PMID: 15635003 Free PMC article.
-
Detection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube sera.J Clin Microbiol. 1996 Sep;34(9):2191-5. doi: 10.1128/jcm.34.9.2191-2195.1996. J Clin Microbiol. 1996. PMID: 8862583 Free PMC article.
-
Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods.J Clin Microbiol. 1998 Jun;36(6):1711-5. doi: 10.1128/JCM.36.6.1711-1715.1998. J Clin Microbiol. 1998. PMID: 9620405 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical